0001104659-19-050142.txt : 20190913 0001104659-19-050142.hdr.sgml : 20190913 20190913163031 ACCESSION NUMBER: 0001104659-19-050142 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190904 FILED AS OF DATE: 20190913 DATE AS OF CHANGE: 20190913 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wolin Jonathan S. CENTRAL INDEX KEY: 0001787587 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36714 FILM NUMBER: 191092893 MAIL ADDRESS: STREET 1: 201 MISSION STREET, SUITE 2375 CITY: SAN FRANCISCO STATE: CA ZIP: 94105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Jaguar Health, Inc. CENTRAL INDEX KEY: 0001585608 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 MISSION STREET, SUITE 2375 CITY: SAN FRANCISCO STATE: CA ZIP: 94105 BUSINESS PHONE: 415-896-5081 MAIL ADDRESS: STREET 1: 201 MISSION STREET, SUITE 2375 CITY: SAN FRANCISCO STATE: CA ZIP: 94105 FORMER COMPANY: FORMER CONFORMED NAME: Jaguar Animal Health, Inc. DATE OF NAME CHANGE: 20130830 3 1 a3.xml 3 X0206 3 2019-09-04 0 0001585608 Jaguar Health, Inc. JAGX 0001787587 Wolin Jonathan S. C/O JAGUAR HEALTH, INC. 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 0 1 0 0 Chief of Staff, CCO & GC Stock Option (right to buy) 30.80 2028-11-28 Common Stock 1428 D Stock Option (right to buy) 1.73 2029-07-24 Common Stock 260513 D Stock Option (right to buy) 1.20 2029-09-05 Common Stock 43500 D Granted pursuant to the Issuer's 2014 Stock Incentive Plan. One quarter of the options vested on August 28, 2019 (the "Initial Vesting Date"), nine months from the date of grant, with the remaining options vesting in equal monthly installments for each month of continuous service, beginning on September 28, 2019, such that it is vested in full on the 3-year anniversary of the Initial Vesting Date. Vests in equal monthly installments beginning on July 24, 2019, with one month of options, or 43,500 options, vested as of the grant date based on the reporting person's number of years of employment with the issuer, such that the grant is vested in full on the 3-year anniversary of the grant date. The option grant was approved by the issuer's board of directors on July 19, 2019, subject to James J. Bochnowski, the chairman of the board of directors, and Karen S. Wright, the former Chief Financial Officer of the issuer, determining the exact number of option shares to be granted per option based on the issuer's fully diluted shares outstanding following the issuer's underwritten public offering that closed on July 23, 2019. Mr. Bochnowski and Ms. Wright certified the exact number of option shares to be granted on July 24, 2019, such that the effective date of the option grant was July 24, 2019. Vests in equal monthly installments for each month of continuous service, beginning on October 5, 2019, such that it is vested in full on the 3-year anniversary of the grant date. /s/ Jonathan S. Wolin 2019-09-13